Skip to main content
Top
Published in: BMC Gastroenterology 1/2013

Open Access 01-12-2013 | Case report

Chronic diarrhea as the presenting feature of primary systemic AL amyloidosis: serendipity or delayed diagnosis?

Authors: Chen Wang, Yue Li, Yali Jin, Weixun Zhou, Yanlin Zhu, Fang Yao, Jiaming Qian

Published in: BMC Gastroenterology | Issue 1/2013

Login to get access

Abstract

Background

Chronic diarrhea in adults is a common symptom with a wide range of underlying etiologies. Although various strategies have been proposed for evaluation, there are still cases with undetermined origins even after extensive workup. Amyloidosis with gastrointestinal (GI) involvement is one of the causes that should be considered in adult patients with chronic diarrhea. We report a case of primary systemic amyloid light-chain (AL) amyloidosis, presenting initially as chronic diarrhea and weight loss.

Case presentation

A 43-year-old man with chronic diarrhea and weight loss was referred to our hospital. Prior to his presentation, extensive evaluation including an exploratory laparotomy was carried out and did not yield any valuable findings. An echocardiography performed after repeated episodes of orthostatic hypotension revealed infiltrative cardiomyopathy. Moreover, biopsies of the terminal ileum revealed amyloid deposition confirmed by Congo Red staining. Finally, a diagnosis of systemic AL amyloidosis was made after hematological workup. Anti-plasma cell therapy did ameliorate his GI symptoms.

Conclusion

Although amyloidosis with GI involvement is a rare cause of chronic diarrhea, it should be considered especially in patients with intestinal malabsorption and extra-GI manifestations, such as orthostatic hypotension. The delayed diagnosis in the present case highlights the importance of recognizing clinical “red flags” not seemingly related to one another, and underscores the need to get intestinal biopsies even with normal endoscopic appearance of the mucosa.
Appendix
Available only for authorised users
Literature
1.
go back to reference Fine KD, Schiller LR: AGA technical review on the evaluation and management of chronic diarrhea. Gastroenterology. 1999, 116: 1464-1486. 10.1016/S0016-5085(99)70513-5.CrossRefPubMed Fine KD, Schiller LR: AGA technical review on the evaluation and management of chronic diarrhea. Gastroenterology. 1999, 116: 1464-1486. 10.1016/S0016-5085(99)70513-5.CrossRefPubMed
2.
go back to reference Case records of the Massachusetts General Hospital: Weekly clinicopathological exercises. Case 43–1985. A 70-year-old man with diarrhea, weight loss, and recurrent atrial fibrillation. N Engl J Med. 1985, 313: 1070-1079. 10.1056/NEJM198510243131708.CrossRef Case records of the Massachusetts General Hospital: Weekly clinicopathological exercises. Case 43–1985. A 70-year-old man with diarrhea, weight loss, and recurrent atrial fibrillation. N Engl J Med. 1985, 313: 1070-1079. 10.1056/NEJM198510243131708.CrossRef
3.
go back to reference Chakraborty SK, Chowdhury A, Kar S, Mondal S, Basu S, Ahmed AA: Multiple myeloma presenting as malabsorption syndrome due to amyloidosis. J Assoc Physicians India. 2000, 48: 931-932.PubMed Chakraborty SK, Chowdhury A, Kar S, Mondal S, Basu S, Ahmed AA: Multiple myeloma presenting as malabsorption syndrome due to amyloidosis. J Assoc Physicians India. 2000, 48: 931-932.PubMed
4.
go back to reference Siddiqui Z, Osayande AS: Selected disorders of malabsorption. Prim Care. 2011, 38: 395-414. 10.1016/j.pop.2011.05.002.CrossRefPubMed Siddiqui Z, Osayande AS: Selected disorders of malabsorption. Prim Care. 2011, 38: 395-414. 10.1016/j.pop.2011.05.002.CrossRefPubMed
5.
go back to reference Harewood GC, Murray JA: Approaching the patient with chronic malabsorption syndrome. Semin Gastrointest Dis. 1999, 10: 138-144.PubMed Harewood GC, Murray JA: Approaching the patient with chronic malabsorption syndrome. Semin Gastrointest Dis. 1999, 10: 138-144.PubMed
6.
go back to reference Wright JR, Calkins E, Humphrey RL: Potassium permanganate reaction in amyloidosis. A histologic method to assist in differentiating forms of this disease. Lab Invest. 1977, 36: 274-281.PubMed Wright JR, Calkins E, Humphrey RL: Potassium permanganate reaction in amyloidosis. A histologic method to assist in differentiating forms of this disease. Lab Invest. 1977, 36: 274-281.PubMed
7.
go back to reference Menke DM, Kyle RA, Fleming CR, Wolfe JT, Kurtin PJ, Oldenburg WA: Symptomatic gastric amyloidosis in patients with primary systemic amyloidosis. Mayo Clin Proc. 1993, 68: 763-767. 10.1016/S0025-6196(12)60634-X.CrossRefPubMed Menke DM, Kyle RA, Fleming CR, Wolfe JT, Kurtin PJ, Oldenburg WA: Symptomatic gastric amyloidosis in patients with primary systemic amyloidosis. Mayo Clin Proc. 1993, 68: 763-767. 10.1016/S0025-6196(12)60634-X.CrossRefPubMed
8.
go back to reference Tada S, Iida M, Yao T, Kawakubo K, Yao T, Okada M, Fujishima M: Endoscopic features in amyloidosis of the small intestine: clinical and morphologic differences between chemical types of amyloid protein. Gastrointest Endosc. 1994, 40: 45-50. 10.1016/S0016-5107(94)70008-7.CrossRefPubMed Tada S, Iida M, Yao T, Kawakubo K, Yao T, Okada M, Fujishima M: Endoscopic features in amyloidosis of the small intestine: clinical and morphologic differences between chemical types of amyloid protein. Gastrointest Endosc. 1994, 40: 45-50. 10.1016/S0016-5107(94)70008-7.CrossRefPubMed
9.
go back to reference Battle WM, Rubin MR, Cohen S, Snape WJ: Gastrointestinal-motility dysfunction in amyloidosis. N Engl J Med. 1979, 301: 24-25. 10.1056/NEJM197907053010105.CrossRefPubMed Battle WM, Rubin MR, Cohen S, Snape WJ: Gastrointestinal-motility dysfunction in amyloidosis. N Engl J Med. 1979, 301: 24-25. 10.1056/NEJM197907053010105.CrossRefPubMed
10.
go back to reference Petre S, Shah IA, Gilani N: Review article: gastrointestinal amyloidosis - clinical features, diagnosis and therapy. Aliment Pharmacol Ther. 2008, 27: 1006-1016. 10.1111/j.1365-2036.2008.03682.x.CrossRefPubMed Petre S, Shah IA, Gilani N: Review article: gastrointestinal amyloidosis - clinical features, diagnosis and therapy. Aliment Pharmacol Ther. 2008, 27: 1006-1016. 10.1111/j.1365-2036.2008.03682.x.CrossRefPubMed
11.
go back to reference Kastritis E, Wechalekar AD, Dimopoulos MA, Merlini G, Hawkins PN, Perfetti V, Gillmore JD, Palladini G: Bortezomib with or without dexamethasone in primary systemic (light chain) amyloidosis. J Clin Oncol. 2010, 28: 1031-1037. 10.1200/JCO.2009.23.8220.CrossRefPubMed Kastritis E, Wechalekar AD, Dimopoulos MA, Merlini G, Hawkins PN, Perfetti V, Gillmore JD, Palladini G: Bortezomib with or without dexamethasone in primary systemic (light chain) amyloidosis. J Clin Oncol. 2010, 28: 1031-1037. 10.1200/JCO.2009.23.8220.CrossRefPubMed
12.
go back to reference Dimopoulos MA, Terpos E, Chanan-Khan A, Leung N, Ludwig H, Jagannath S, Niesvizky R, Giralt S, Fermand JP, Bladé J, Comenzo RL, Sezer O, Palumbo A, Harousseau JL, Richardson PG, Barlogie B, Anderson KC, Sonneveld P, Tosi P, Cavo M, Rajkumar SV, Durie BG, San Miguel J: Renal impairment in patients with multiple myeloma: a consensus statement on behalf of the International Myeloma Working Group. J Clin Oncol. 2010, 28: 4976-4984. 10.1200/JCO.2010.30.8791.CrossRefPubMed Dimopoulos MA, Terpos E, Chanan-Khan A, Leung N, Ludwig H, Jagannath S, Niesvizky R, Giralt S, Fermand JP, Bladé J, Comenzo RL, Sezer O, Palumbo A, Harousseau JL, Richardson PG, Barlogie B, Anderson KC, Sonneveld P, Tosi P, Cavo M, Rajkumar SV, Durie BG, San Miguel J: Renal impairment in patients with multiple myeloma: a consensus statement on behalf of the International Myeloma Working Group. J Clin Oncol. 2010, 28: 4976-4984. 10.1200/JCO.2010.30.8791.CrossRefPubMed
13.
go back to reference Madsen LG, Gimsing P, Schiødt FV: Primary (AL) amyloidosis with gastrointestinal involvement. Scand J Gastroenterol. 2009, 44: 708-711.CrossRefPubMed Madsen LG, Gimsing P, Schiødt FV: Primary (AL) amyloidosis with gastrointestinal involvement. Scand J Gastroenterol. 2009, 44: 708-711.CrossRefPubMed
Metadata
Title
Chronic diarrhea as the presenting feature of primary systemic AL amyloidosis: serendipity or delayed diagnosis?
Authors
Chen Wang
Yue Li
Yali Jin
Weixun Zhou
Yanlin Zhu
Fang Yao
Jiaming Qian
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2013
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/1471-230X-13-71

Other articles of this Issue 1/2013

BMC Gastroenterology 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.